DRW Securities’s NeoGenomics NEO Stock Holding History

DRW Securities’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,890	Closed	-$200K	–	1321
2026 Q1	$200K	Buy	+26,890	New	+$283K	﹤0.01%	1120

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

DRW Securities's NEO Position: Q2 2026 in Review

DRW Securities sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 26,890 shares — an estimated $200K sold.

DRW Securities first reported a position in NEO in Q1 2026 and held it in 1 quarter. The position peaked at $200K in Q1 2026. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

DRW Securities reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
DRW Securities sold 26,890 NeoGenomics shares in Q2 2026, an estimated $200K.
DRW Securities first reported a position in NeoGenomics in Q1 2026 and held it in 1 quarter.
DRW Securities's NeoGenomics position peaked at $200K in Q1 2026.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.